Celldex Therapeutics CLDX
NASDAQ CLDX
$32.41 +0.77 (+2.43%)
As of: Sep 30, 2026 · 3:59 PM EDT

Celldex Therapeutics (CLDX) Operating Margin (2010 - 2026)

Updated

Celldex Therapeutics' Operating Margin was -366468.18% in Q2 2026, down 357720.65 percentage points from -8747.53% a year earlier but up 196431.82 percentage points from the prior quarter.

Analysis

Celldex Therapeutics (CLDX) Operating Margin (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Celldex Therapeutics' Operating Margin was -206220.25% through Jun 30, 2026, down 202166.57 percentage points year-over-year; for FY2025, it was -18599.81%, down 15820.92 percentage points from FY2024.

  • Operating Margin shows a five-year change of -17745.75 percentage points (FY2020 to FY2025).
  • In earlier years, Operating Margin was -2778.89% in FY2024 (-533.62 pp), -2245.27% in FY2023 (+2643.74 pp), -4889.01% in FY2022 (-3357.23 pp) and -1531.78% in FY2021 (-677.72 pp).
  • Quarterly Operating Margin has moved between -562900.00% (Q1 2026) and -1152.92% (Q4 2023) over five years.
  • Compared with a year earlier, Operating Margin has declined for three straight quarters, with an average year-over-year change of -138753.24 percentage points over the last seven quarters.
  • The best year-over-year quarter for Operating Margin over five years was Q1 2025 (a gain of 17003.57 percentage points); the worst was Q1 2026 (a drop of 553872.81 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Celldex Therapeutics 2.48 Bn 2.48 Bn - -366,468.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -366,468.18%
Mar 31, 2026 -562,900.00%
Dec 31, 2025 -72,027.27%
Jun 30, 2025 -8,747.53%
Mar 31, 2025 -9,027.19%
Dec 31, 2024 -4,768.26%
Sep 30, 2024 -1,633.53%
Jun 30, 2024 -1,854.16%
Mar 31, 2024 -26,030.77%
Dec 31, 2023 -1,152.92%
Sep 30, 2023 -2,718.46%
Jun 30, 2023 -12,389.93%
Mar 31, 2023 -3,357.91%
Dec 31, 2022 -1,728.77%
Sep 30, 2022 -6,804.91%
Jun 30, 2022 -22,328.83%
Mar 31, 2022 -13,366.09%
Dec 31, 2021 -6,089.82%
Sep 30, 2021 -13,610.46%
Jun 30, 2021 -386.21%
API Access

Celldex Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=CLDX&period=max&api_key=YOUR_API_KEY